Artificial Intelligence‐Guided Phenotypic Drug Repurposing Against Streptococcus pneumoniae
ABSTRACT The prevalence of antimicrobial resistance (AMR) within the common bacterial pathogen Streptococcus pneumoniae makes it a priority for the development of new antibiotics. While artificial intelligence (AI) has recently boosted phenotype‐based repurposing of drugs for other human pathogens, this remains to be i...